The global balloon catheters market size was valued at USD 4.5 billion in 2023, with Europe holding a significant market share. The market is driven by the increasing prevalence of cardiovascular diseases. It is expected to grow at a CAGR of 10.60% during the forecast period of 2024-2032, with the values likely to attain USD 8.1 billion by 2032.
In Europe, the high prevalence rate of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, drives the demand for balloon catheters. Recent data reveals that Eastern Europe has the highest cardiovascular disease death rates, with 553 deaths for every 100,000 individuals, indicating the urgent need for interventions that involve balloon catheters, such as angioplasty. Further, the growing aging population coupled with the presence of advanced healthcare infrastructure and high healthcare spending is expected to influence the Europe balloon catheters market share.
One of the major market trends is the increased merger and acquisition activities to accelerate the market expansion of complex coronary interventions including balloon catheter technology. In June 2023, Netherlands-based balloon catheter manufacturer Blue Medical Devices was acquired by a global interventional cardiovascular device company Translumina to expand its intervention cardiology portfolio. Through this acquisition, the company is expected to gain access for Drug Coated Balloons (DCB) and other specialty balloons, that can offer new treatment possibilities to cardiovascular patients. Such strategic partnerships are expected to increase access to innovative balloon catheters across the region, thereby fuelling market growth.
The Europe balloon catheters market is expected to be driven by the rising demand for the global balloon catheters market, which is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 and is likely to reach a market value of USD 8.1 billion by 2032.
What are the major factors aiding the Europe balloon catheters market demand?
The high prevalence rate of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is fuelling the demand for the market.
What are the major Europe balloon catheters market trends?
One of the significant trends in the market is the increased merger and acquisition activities to accelerate the market expansion of complex coronary interventions including balloon catheter technology. In June 2023, Netherlands-based balloon catheter manufacturer Blue Medical Devices was acquired by Translumina to expand its intervention cardiology portfolio.
What is the market segmentation based on the product type?
Based on the product type, the market is segmented into PTA balloon catheters, PTCA balloon catheters, occlusion balloon catheters, foley catheters, nephrostomy balloon catheters, drug-eluting catheters, normal balloon catheter, cutting balloon catheter, scoring balloon catheter, drug eluting balloon catheter, and stent graft balloon catheter, among others.
What is the market segmentation based on the catheter type?
Based on the catheter type, the market is segmented into fixed wire, over-the-wire, and rapid exchange catheter.
What is the market breakup by balloon type?
Based on the balloon type, the market includes non-compliant, semi-compliant, and compliant catheters.
What is the market breakup by material?
Based on the material, the market includes polyurethane, and nylon, among others.
What is the market breakup by indication?
Based on indication, the market includes coronary artery disease and peripheral vascular disease.
What are the major end users of balloon catheters in Europe?
Major end users include hospitals and specialty clinics, among others.
What is the market segmentation by countries?
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
Who are the key players involved in the Europe balloon catheters market?
The key players in the market are Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Bard Medical Division, B.Braun Melsungen AG, Johnson & Johnson, Teleflex Incorporated, Medtronic, Plc., Edwards Lifesciences Corporation, and Vascular Solutions, Inc.
This product will be delivered within 5-7 business days.
Key Takeaways
- Recent data reveals that Eastern Europe has the highest cardiovascular disease death rates, with 553 deaths for every 100,000 individuals. The high prevalence rate of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, drives the demand for balloon catheters in the region.
- One of the major Europe balloon catheters market trends is the increased merger and acquisition activities to accelerate the market expansion of complex coronary interventions including balloon catheter technology. In June 2023, Medical Devices was acquired by Translumina to expand its intervention cardiology portfolio . Such strategic partnerships are expected to increase access to innovative balloon catheters.
- The increased focus on minimally invasive surgeries significantly elevates the market value, driving both the development and adoption of balloon catheters across the region.
Europe Balloon Catheters Market Analysis
Balloon catheters are medical devices that are primarily utilized in minimally invasive procedures to treat narrowed or blocked vessels. The catheter is a thin and flexible tube made from medical-grade materials and a balloon is attached to its tip, which can be inflated and deflated. The rising preference for balloon catheters can be attributed to the growing demand for minimally invasive surgeries, which significantly contributes to the Europe balloon catheters market growth.In Europe, the high prevalence rate of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, drives the demand for balloon catheters. Recent data reveals that Eastern Europe has the highest cardiovascular disease death rates, with 553 deaths for every 100,000 individuals, indicating the urgent need for interventions that involve balloon catheters, such as angioplasty. Further, the growing aging population coupled with the presence of advanced healthcare infrastructure and high healthcare spending is expected to influence the Europe balloon catheters market share.
One of the major market trends is the increased merger and acquisition activities to accelerate the market expansion of complex coronary interventions including balloon catheter technology. In June 2023, Netherlands-based balloon catheter manufacturer Blue Medical Devices was acquired by a global interventional cardiovascular device company Translumina to expand its intervention cardiology portfolio. Through this acquisition, the company is expected to gain access for Drug Coated Balloons (DCB) and other specialty balloons, that can offer new treatment possibilities to cardiovascular patients. Such strategic partnerships are expected to increase access to innovative balloon catheters across the region, thereby fuelling market growth.
Europe Balloon Catheters Market Segmentation
Market Breakup by Product Type
- PTA Balloon Catheters
- PTCA Balloon Catheters
- Occlusion Balloon Catheters
- Foley Catheters
- Nephrostomy Balloon Catheters
- Drug-Eluting Catheters
- Normal Balloon Catheter
- Cutting Balloon Catheter
- Scoring Balloon Catheter
- Drug Eluting Balloon Catheter
- Stent Graft Balloon Catheter
- Others
Market Breakup by Catheter Type
- Fixed Wire
- Over-The-Wire
- Rapid Exchange
Market Breakup by Balloon Type
- Non-Compliant
- Semi-Compliant
- Compliant
Market Breakup by Material
- Polyurethane
- Nylon
- Others
Market Breakup by Indication
- Coronary Artery Disease
- Peripheral Vascular Disease
Market Breakup by End User
- Hospitals
- Specialty Clinics
- Others
Market Breakup by Countries
- United Kingdom
- Germany
- France
- Italy
- Others
Europe Balloon Catheters Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Abbott Laboratories
- Becton Dickinson and Company
- Boston Scientific Corporation
- Bard Medical Division
- B.Braun Melsungen AG
- Johnson & Johnson
- Teleflex Incorporated
- Medtronic, Plc.
- Edwards Lifesciences Corporation
- Vascular Solutions, Inc.
FAQs
What is the Europe balloon catheters market forecast outlook for 2024-2032?The Europe balloon catheters market is expected to be driven by the rising demand for the global balloon catheters market, which is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 and is likely to reach a market value of USD 8.1 billion by 2032.
What are the major factors aiding the Europe balloon catheters market demand?
The high prevalence rate of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is fuelling the demand for the market.
What are the major Europe balloon catheters market trends?
One of the significant trends in the market is the increased merger and acquisition activities to accelerate the market expansion of complex coronary interventions including balloon catheter technology. In June 2023, Netherlands-based balloon catheter manufacturer Blue Medical Devices was acquired by Translumina to expand its intervention cardiology portfolio.
What is the market segmentation based on the product type?
Based on the product type, the market is segmented into PTA balloon catheters, PTCA balloon catheters, occlusion balloon catheters, foley catheters, nephrostomy balloon catheters, drug-eluting catheters, normal balloon catheter, cutting balloon catheter, scoring balloon catheter, drug eluting balloon catheter, and stent graft balloon catheter, among others.
What is the market segmentation based on the catheter type?
Based on the catheter type, the market is segmented into fixed wire, over-the-wire, and rapid exchange catheter.
What is the market breakup by balloon type?
Based on the balloon type, the market includes non-compliant, semi-compliant, and compliant catheters.
What is the market breakup by material?
Based on the material, the market includes polyurethane, and nylon, among others.
What is the market breakup by indication?
Based on indication, the market includes coronary artery disease and peripheral vascular disease.
What are the major end users of balloon catheters in Europe?
Major end users include hospitals and specialty clinics, among others.
What is the market segmentation by countries?
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
Who are the key players involved in the Europe balloon catheters market?
The key players in the market are Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Bard Medical Division, B.Braun Melsungen AG, Johnson & Johnson, Teleflex Incorporated, Medtronic, Plc., Edwards Lifesciences Corporation, and Vascular Solutions, Inc.
This product will be delivered within 5-7 business days.
Table of Contents
1 Preface
3 Europe Balloon Catheters Market Overview
4 Europe Balloon Catheters Market Landscape*
5 Europe Balloon Catheters Market Dynamics
6 Europe Balloon Catheters Market Segmentation (2017-2032)
7 United Kingdom Balloon Catheters Market (2017-2032)
8 Germany Ballon Catheters Market (2017-2032)
9 France Ballon Catheters Market (2017-2032)
10 Italy Ballon Catheters Market (2017-2032)
12 Patent Analysis
13 Funding and Investment Analysis
14 Partnership and Collaborations Analysis
15 Supplier Landscape
16 Europe Balloon Catheters Market - Distribution Model (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
19 Payment Methods (Additional Insight)
Companies Mentioned
- Abbott Laboratories
- Becton Dickinson and Company
- Boston Scientific Corporation
- Bard Medical Division
- B.Braun Melsungen AG
- Johnson & Johnson
- Teleflex Incorporated
- Medtronic Plc.
- Edwards Lifesciences Corporation
- Vascular Solutions Inc.
Methodology
LOADING...
